Recently, CD44 expression level was reported to be correlated with PCa grade in prostate biopsy samples [30], and proteomics analysis showed that CD44+ cells had positive correlation with genes related to cancer proliferation and metastasis [31]. This evidence concerns the gene CD44 and cancer.